Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.36 |
| ▸ | CHRM4 known ✓ | P08173 | 2/20 | 0.36 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.36 |
| ▸ | CHRM5 known ✓ | P08912 | 1/20 | 0.34 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.34 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | GALR3 | O60755 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1131168 | 0.97 | MAPT (0.44) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| Hydrochloric Acid SCHEMBL146731 | 0.94 | MAPT (0.48) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| Hydrochloric Acid SCHEMBL2341007 | 0.90 | HSD17B10 (0.50) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| Hydrochloric Acid SCHEMBL5479517 | 0.87 | HSD17B10 (0.41) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| SCHEMBL13481161 | 0.87 | USP2 (0.47) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| SCHEMBL3833772 | 0.87 | HSD17B10 (0.52) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| SCHEMBL30603364 | 0.86 | HSD17B10 (0.44) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| Hydrochloric Acid SCHEMBL2341008 | 0.85 | HSD17B10 (0.50) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| Hydrochloric Acid SCHEMBL3032024 | 0.85 | HSD17B10 (0.50) | MAPTKDM4ESLC22A16TSHRCHRM2 | |
| SCHEMBL14436072 | 0.85 | USP2 (0.45) | MAPTKDM4ESLC22A16TSHRCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 529 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109111857-B | Polishing solution and application thereof to polishing of 2.5D zirconia ceramic plate | 北京保利世达科技有限公司 | 2020-10-16 | — | — | CN | claimed |
| US-12529014-B2 | Polyurethane redeposition inhibiting polymers and detergent compositions containing same | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-12460160-B2 | Redeposition inhibiting styrene maleic anhydride copolymers and detergent compositions containing same | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12416114-B2 | Fabric spray containing lactilol for malodour reduction | CONIPCO, INC. (US) | 2025-09-16 | — | — | US | disclosed |
| EP-3694964-B1 | AQUEOUS SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025078195-A1 | FABRIC SPRAY | UNILEVER IP HOLDINGS B.V. (NL) | 2025-04-17 | — | — | WO | disclosed |
| EP-3694965-B1 | AQUEOUS SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-02-12 | — | — | EP | disclosed |
| US-20250043032-A1 | FUNCTIONALIZED CYCLODEXTRIN MONOMER AND POLYMER FOR WATER REMEDIATION | UNIV NORTHWESTERN (US) | 2025-02-06 | — | — | US | disclosed |
| US-20240375084-A1 | SUPRAMOLECULAR GOLD STRIPPING FROM ACTIVATED CARBON USING ALPHA-CYCLODEXTRIN | NATIONAL SCIENCE FOUNDATION | 2024-11-14 | — | — | US | disclosed |
| EP-4278035-B1 | METHOD FOR SPRAYING LAUNDRY | UNILEVER IP HOLDINGS B V (NL) | 2024-10-23 | — | — | EP | disclosed |
| US-5670475-A | DEODORIZING SURFACES WITH PERFUMES AND CYCLODEXTRINS | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-23 | — | — | US | disclosed |
| US-5668097-A | DEODORIZING OF TEXTILE SURFACES | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-16 | — | — | US | disclosed |
| US-5663134-A | DEODORIZING | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-02 | — | — | US | disclosed |
| EP-0776220-A1 | FABRIC TREATING COMPOSITION CONTAINING BETA-CYCLODEXTRIN | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0774980-A1 | COMPOSITION FOR REDUCING MALODOR IMPRESSION ON INANIMATE SURFACES | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| US-5593670-A | ODOR ABSORBER FOR FABRICS | THE PROCTOR & GAMBLE COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5578563-A | CLOTHING | THE PROCTER & GAMBLE COMPANY (US) | 1996-11-26 | — | — | US | disclosed |
| US-5534165-A | Fabric treating composition containing beta-cyclodextrin and essentially free of perfume | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-09 | — | — | US | disclosed |
| WO-1996004940-A1 | COMPOSITION FOR REDUCING MALODOR IMPRESSION ON INANIMATE SURFACES | THE PROCTER & GAMBLE COMPANY (US) | 1996-02-22 | — | — | WO | disclosed |
| WO-1996004939-A1 | FABRIC TREATING COMPOSITION CONTAINING BETA-CYCLODEXTRIN | THE PROCTER & GAMBLE COMPANY (US) | 1996-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529014-B2 | Polyurethane redeposition inhibiting polymers and detergent compositions containing same | PUF60, XRCC6, SDC2 | CHRM2 1605/4885CHRM4 2881/4885CHRM1 2406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.